Abstract:Objective To investigate the expressions of CD133 and CD44 protein in primary lesions of gastric cancer and its clinical significance. Methods The expressions of CD44 and CD133 protein in gastric cancer tissues of100 patients with gastric cancer were detected by immunohistocheimcal stainings. The relation between the expressions of CD44 and CD133 protein and the clinicopathologic characters were analyzed. Results Both CD44 and CD133protein were expressed on the cell membranes. No correlation were found between CD44/CD133 and the clinicopathologic parameters include gender and age(P0.05), but the positive expression rate of CD44/CD133 with diameter5 cm was significantly higher than that tumor with diameter ≤5 cm(CD44 P=0.150;CD133 P=0.056), and correlated with the tissue differentiation(CD44 P=0.008;CD133 P=0.007), vascular invasion(CD44 P=0.043;CD133 P=0.023), lymphatic vessel invasion(CD44 P=0.020;CD133 P=0.044), lymph nodes metastasis(CD44 P=0.002;CD133 P=0.004), invasion depth of tumor(CD44 P=0.006;CD133 P=0.021), and pTNM stage(CD44 P=0.034;CD133 P=0.001). No correlation were found between the co-expression of CD44 and CD133 protein and the clinicopathologic parameters include gender, age, tissue differentiation, and vascular invasion(P0.05), but the positive co-expression rate of CD44 and CD133 with diameter 5 cm was significantly higher than that tumor with diameter ≤5 cm(P=0.010), and correlated with lymphatic vessel invasion(P=0.003), lymph nodes metastasis(P=0.045), invasion depth of tumor(P=0.041), and pTNM stage(P=0.049). The Spearman rank correlation analysis showed that there was positive correlation between the expressions of CD44 and CD133 protein(r =0.207, P=0.039). Univariate analysis showed that lymph nodes metastasis(P0.001), pTNM stages(P=0.013), CD44 protein expression(P=0.005), CD133 protein expression(P=0.002), and co-expression of CD44 and CD133 protein(P0.001) were significantly correlated with 3-year survival rate of patients with gastric cancer respectively. Logistic regression analysis revealed that lymph node metastasis(P=0.038) was independent risk factor for co-expression of CD44 and CD133 protein. Multivariate analysis with the Cox regression models showed that co-expression of CD44 and CD133 protein(P=0.003) and lymph node metastasis(P=0.006) were significantly associated with poor prognosis. Conclusions CD44 and CD133 protein may be considered as robust cancer stem cell markers in gastric cancer. The co-expression of CD44 and CD133 protein is the independent prognosis factor for gastric cancer and strongly associated with poor prognosis when they are expressed more high.

Study on the expression of receptor for hyaluronan-mediated motility and CD44 in gastroenteric cancer by real-time reverse transcriptase polymerase chain reaction

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

Expression of the RON Receptor Tyrosine Kinase and Its Association with Gastric Carcinoma Versus Normal Gastric Tissues.

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

The Role of Vascular Endothelial Growth Factor Receptor (KDR) in Invasion and Metastasis of Gastric Cancer

Expression of CD44v5 in Gastric Cancer:Relationships with Lymph Node Metastasis

A study of adhesive molecule CD44S CD44V variant expression in gastric carcinoma with RT-PCR

[Quantitative Studies on Expression of Peripheral Blood CD44 and CD54 in Non-Small Cell Lung Carcinoma].

Expressions of CD133 and CD44 Protein in Primary Lesion of Gastric Cancer and Its Clinical Significance

Expression of CD44 Mrna in Human Colorectal Tumors

The Expression of CD44v6 Mrna in Human Gastric Cancer

Expression and corelation of activated c-Src protein tyrosine kinase, HER2 and Ki-67 in gastric cancer

The Expression of CD44v5+ Cells in Different Tissue of Patients with Gastric Carcinoma

CD44s expression study in colorectal cancer tissues

Research on the Correlation among Expression Rates of CD44s,CD44V5 and CD44V6 in Peripheral Blood Cells of Patients with Colorectal Carcinoma

Expression of RhoA and RhoC in Colorectal Carcinoma and Its Relations with Clinicopathological Parameters.

Role of CD97stalkand CD55 As Molecular Markers for Prognosis and Therapy of Gastric Carcinoma Patients

The Expression and Meaning of CD44 and Metalloproteinase-2 in Breast Cancer

[Relationship Between CD44 Expression or Glycosylation and Hepatocellular Carcinoma Metastasis].

Molecular Biology of RHAMM and Its Relationship with Cancer

Expression and clinical significance of CD44 and Ezrin in the process of metastasis in human primary sporadic colorectal carcinoma